Table 2.
Independent Multivariable Predictors of ≥ 7% Weight Gain in the First Year of Antipsychotic Drug Therapy
| Independent Variables | OR | 95% CI | χ2 | P Value |
|---|---|---|---|---|
| Olanzapine use | 2.8 | 1.7 to 4.6 | 17.8 | <.0001 |
| Risperidone use | 2.3 | 1.5 to 3.4 | 15.4 | <.0001 |
| Schizophrenia | 0.7 | 0.4 to 1.2 | 1.8 | .2 |
| Depression | 1.2 | 0.8 to 1.7 | 0.7 | .4 |
| Anxiety | 1.2 | 0.8 to 1.9 | 1.1 | .3 |
| Personality disorder | 0.8 | 0.5 to 1.5 | 0.5 | .5 |
| Dementia | 0.8 | 0.4 to 1.4 | 0.8 | .4 |
| Alcohol abuse | 1.1 | 0.7 to 1.6 | 0.1 | .8 |
| Drug abuse | 1.1 | 0.6 to 2.0 | 0.02 | .9 |
| Obesity | 1.3 | 0.8 to 2.0 | 1.2 | .3 |
| Cognitive dysfunction | 1.1 | 0.8 to 1.6 | 0.2 | .6 |
| Primary care visits | 0.98 | 0.97 to 1.0 | 0.28 | .1 |
| Mental health visits* | 1.0 | 1.0 to 1.01 | 0.6 | .4 |
| Emergency visits | 1.0 | 1.00 to 1.02 | 2.5 | .1 |
| Baseline weight, lb | 0.99 | 0.96 to 0.99 | 38.2 | <.0001 |
Odds ratio for 10 visits.
OR, adjusted odds ratio; CI, confidence interval.